Novel anti-cancer drugs - Novel anti-cancer drugsNovel anti-cancer drugsNovel anti-cancer drugs

  • Telphone : 123456789
  • Email Address: info@labtechco.com
CONSULTATION
  • Home
  • About Us
    • Leadership
    • R&D center
    • Partnerships
  • Our Product
    • Features
    • Approach
    • Pipeline
  • Our Science
    • Mechanism
    • Publications
  • News & Media
    • New updates
    • Press release
  • Investors Resources
    • General Info
    • Corporate Governance
    • Financial Statements
  • Contacts

News & Media

PRESS RELEASE

Pet Medical Care

Gongwin’s Compassionate treatment

Gongwin-KY Adopted Compassionate Treatme

Gongwin-KY Completed Case Acceptance for

Gongwin-KY’s endeavors in furry baby can

Zhong Nanshan led Gongwin-KY, the pionee

Gongwin-KY joins hands with three major

2019-11-21 Gongwin-KY Aims at Huge Busin...

2019-11-21 Gongwin-KY’s Liver Cancer New.....Read More

2019-4-12 Gongwin Biopharm Joins Hands...

2019-01-21 Gongwin-KY's Lung Cancer New ...

Gongwin-KY’s skin topical series formula...

Gongwin-KY’s liver cancer new drug PTS10...

"Emerging Market stock" Gongwin-KY was a...

Gongwin-KY’s new drug for adenoid cystic...

NEW UPDATES

Companion Animal Treatment Performance C...

Gongwinbiopharm granted for MUMS sponsor...

Canine Melanoma Field Trial Approved by ...

Canine Melanoma Field Trial Approved by ...

PTS302 receives Official Market Approval...

BIO One-on-One Partnering™

Gongwin Biopharm Holdings, Co., Ltd. Cayman (Gongwin-KY; ticker: 6617) founded in 2014 is a Taiwan based clinical stage biopharmaceutical company focused on developing novel anti-cancer drugs.

USEFUL LINKS

  • About Us
  • Pipeline
  • Leadership
  • Contacts
  • Research

OUR SERVICES

  • Scientific
  • Chemistry
  • Gemological
  • Forensic science
  • Immunology

Address

3F., No.80, Sec. 1, Jianguo N. Rd., Zhongshan Dist., Taipei City 104, Taiwan (R.O.C.)

Copyright © 2025 Gongwinbiopharm. All rights reserved.